AbbVie Reports Second-Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
AbbVie (ABBV) Tops Q2 EPS by 2c, Offers FY Guidance
July 28, 2017 7:43 AM EDTAbbVie (NYSE: ABBV) reported Q2 EPS of $1.42, $0.02 better than the analyst estimate of $1.40. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.92 billion.
GUIDANCE:
AbbVie sees FY2017 EPS of $5.44-$5.54, versus the consensus of $5.53.
For earnings history and earnings-related data on AbbVie (ABBV) click here.
... More